go back

Nevada rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,174,898 · 10th–90th $0–$1,479,1080%50%10th90th$1,174,898Professionalmedian $588,844 · 10th–90th $588,844–$2,238,7210%50%90th$588,844$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$588,843.66 / $1,174,897.55 / $1,479,108.39
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $2,238,721.14
Anthem BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$0.03 / $0.03 / $0.03
Anthem BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66
Hometown Health
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66
Select Health
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $660,693.45 / $758,577.58